Group 1 - Morgan Stanley increased its stake in Hong Kong Exchanges and Clearing Limited (00388) by 681,221 shares at a price of HKD 433.4691 per share, totaling approximately HKD 295 million [1] - Following the increase, Morgan Stanley's total shareholding in Hong Kong Exchanges and Clearing Limited reached approximately 89,210,200 shares, representing a holding percentage of 7.03% [1]

中新社香港10月31日电 (记者 戴小橦)10月31日，来到10月最后一个交易日，港股市场呈现调整态势， 三大指数同步走弱。而纵观整个10月，港股IPO市场热度持续高企，单月有超过10家公司成功登陆香港 交易及结算所有限公司(简称"港交所")，市场结构性分化特征愈发鲜明。 银河证券发布研究报告指出，医药板块近期已呈现显著结构性修复趋势。当前二级市场行情回暖驱动一 级市场投融资回升，医疗器械招投标数据已有好转，以旧换新积压需求逐步释放。 方正证券发布的研究报告表示，医药行业景气度正步入新一轮上行周期。行业"出海"订单加速释放，且 整体尚处于成长早期，向上动能强劲。报告看好"出海"能力突出的生物品类上游公司，相信创新药"出 海"将迎来机遇。 招商证券发布研报称，美联储降息促使美国与新兴市场利差收窄、美元走弱，从而吸引国际资金流入香 港等新兴市场，港股中长期有望呈现渐进式上涨。与此同时，美联储降息周期亦有望改善创新药领域的 融资环境，推动研发进展。 31日，港股三大指数齐跌，香港恒生指数跌1.43%，恒生科技指数跌2.37%，国企指数跌1.91%。(完) 10月31日，香港恒生指数收市报25906.65点，下跌37 ...

Core Viewpoint - Hong Kong Exchanges and Clearing (HKEX) is expected to report strong financial results for Q3 2025, driven by increased trading activity and a robust IPO market, despite a decline in investment income due to lower HIBOR rates and currency fluctuations [1][2][3] Group 1: Financial Performance - Total revenue for Q3 2025 is projected to be HKD 7.583 billion, representing a year-on-year increase of 41% and a quarter-on-quarter increase of 5% [1] - Net profit attributable to shareholders is expected to reach HKD 4.774 billion, reflecting a year-on-year growth of 52% and a quarter-on-quarter growth of 7% [1] - Daily average trading volume (ADT) for Hong Kong stocks is anticipated to be HKD 286.4 billion, marking a year-on-year increase of 141% and a quarter-on-quarter increase of 20% [1] Group 2: Trading Activity - Trading-related revenue is expected to rise to HKD 5.137 billion, a quarter-on-quarter increase of 31% [1] - Southbound trading volume reached HKD 76.2 billion, a quarter-on-quarter increase of 36%, accounting for 26.6% of total ADT [1] - Northbound trading activity saw a significant increase, with single-sided ADT reaching RMB 134.3 billion, up 77% quarter-on-quarter [1] Group 3: IPO Market - IPO-related revenue for Q3 2025 is estimated at HKD 440 million, a quarter-on-quarter increase of 7.5% [2] - A total of 25 IPOs were recorded in Q3 2025, with a fundraising amount of HKD 73.5 billion, down from HKD 88 billion in Q2 2025 [2] - The number of newly listed structured products increased to 10,700, up from 9,494 in the previous quarter [2] Group 4: Investment Income - Net investment income is projected to decline to HKD 917 million, a quarter-on-quarter decrease of 41% [2] - The decline is attributed to reduced margins from margin investments due to HIBOR fluctuations and a decrease in the company's own investment returns [2] Group 5: Profit Forecast and Valuation - Net profit forecasts for 2025, 2026, and 2027 have been adjusted to HKD 17.7 billion, HKD 18.3 billion, and HKD 18.7 billion, respectively, with increases of 5.2%, 11.2%, and 14.1% [3] - The target price based on DCF remains at HKD 542, with a cost of equity of 5% [3]

Core Viewpoint - The London Metal Exchange (LME) plans to establish permanent rules to limit large positions in near-month contracts when inventories are low, aiming to maintain market order and prevent manipulation [1][2]. Group 1: Inventory and Market Conditions - LME copper inventory dropped from 248,000 tons in February to 99,200 tons in June, a decline of 60%, leading to a significant increase in copper premiums [1]. - Zinc inventory has decreased by approximately 85% this year, with current available stock at only 24,425 tons, insufficient to meet one day's global consumption [2]. - The premium for near-month zinc contracts surged to a historical high of $339 per ton, reflecting the impact of low inventory on market dynamics [2]. Group 2: Temporary and Permanent Measures - The temporary measures introduced in June required holders of long positions exceeding total inventory levels to lend metal back to the market at zero premium, successfully reducing large aluminum positions held by entities like Mercuria [1]. - The proposed permanent rules will extend the temporary measures, mandating that any participant holding long positions above total inventory must lend metal at zero premium and will broaden the restrictions on "tom-next" positions [2]. Group 3: Regulatory Transition and Industry Impact - The public consultation period for the permanent rules will last until November 21, with the changes seen as a preparation for LME's authority over market position limits starting July 2026 [3]. - The implementation of permanent rules is expected to limit speculative capital's ability to manipulate the market due to low inventories, although it may affect hedging operations for some entities [3].

Group 1: Core Insights - The integration of technological innovation and financial services is becoming a key driver of economic growth amid profound changes in the global economic landscape [1] - The 2025 Financial Street Forum focused on the theme of "Innovation, Cooperation, and Openness" in the context of global economic restructuring [1] Group 2: Institutional Support - A robust capital market ecosystem tailored to the needs of innovative enterprises requires top-level design and institutional guarantees [2] - The Ministry of Industry and Information Technology emphasizes enhancing the innovation capabilities and specialization of small and medium-sized enterprises (SMEs) through a comprehensive policy framework [2] - The China Securities Regulatory Commission (CSRC) aims to strengthen the multi-tiered capital market's support for technological innovation by focusing on market dynamics, optimizing regulatory arrangements, and deepening institutional innovation [2] Group 3: Judicial and Market Mechanisms - The Beijing Financial Court is working on improving judicial rules related to investment and financing to empower technological innovation [3] - The Beijing Stock Exchange is committed to supporting innovative SMEs by creating a market ecosystem that aligns with their characteristics [3] Group 4: Macro Economic Transition - The shift from a "land-finance-financial" cycle to an "industry-technology-financial" cycle is highlighted as a significant transformation in China's economic structure [4] - Recommendations include addressing financial support bottlenecks for technological innovation and accelerating financial internationalization [4] Group 5: Global Experience and Best Practices - The increasing openness of China's capital market is leading to the adoption of international experiences and innovative tools to enhance support for technology enterprises [5] - The Singapore Exchange and London Stock Exchange are cited for their unique advantages in supporting innovative and growth-oriented companies [5][6] Group 6: Market Performance and Initiatives - As of September 30, the IPO fundraising amount reached $23.9 billion, representing a 230% increase compared to the same period last year, making it the top global exchange for IPOs [7] - The Hong Kong Stock Exchange reported strong performance across all nine industry sectors, with significant growth in the healthcare and biotechnology sectors [6][7]

Core Viewpoint - The 10th China Pharmaceutical Innovation and Investment Conference highlighted the significant role of capital markets in supporting the globalization of Chinese innovative pharmaceutical companies, with Hong Kong Stock Exchange (HKEX) emerging as a leading platform for biotech financing in 2023 [1] Group 1: Market Performance - HKEX has positioned itself as a vital international financing platform for Chinese biotech companies, with the healthcare sector's IPO financing in Hong Kong ranking first globally this year [1] - As of now, Hong Kong has completed 12 biotech IPOs, raising a total of $1.3 billion, which is the highest globally [1] - The total amount raised through refinancing in the biotech sector has reached $4.1 billion this year, indicating a recovery in market confidence [1] Group 2: Regulatory Environment - The recent strong performance of Hong Kong's healthcare financing market is attributed to three interlinked factors: continuous optimization of regulatory systems, the listing of high-quality innovative companies, and active participation from investors [1] - The market is expected to see a significant rebound by 2025, reaffirming Hong Kong as the preferred listing destination for biotech companies [1]

Group 1: Economic Growth and Financial Center Status - Hong Kong aims to strengthen its stock market and deepen financial connectivity with mainland China to accelerate new economic growth points and opportunities [1][2] - In the latest Global Financial Centers Index, Hong Kong ranks third globally and first in Asia, with a narrow score difference from the top two centers [1] - The average daily trading volume in Hong Kong's stock market exceeded HKD 250 billion in the first nine months of the year, doubling from the previous year [1] Group 2: Stock Market and Capital Raising - New stock fundraising in Hong Kong reached over HKD 180 billion by the end of September, marking a year-on-year increase of over 200%, making it the highest globally [1] - The Hong Kong government will assist mainland tech companies in financing through a newly established "Tech Enterprise Line" and encourage Chinese companies listed overseas to return to Hong Kong [1] Group 3: Connectivity with Mainland Financial Markets - The average daily trading volume for northbound trading under the Stock Connect exceeded RMB 200 billion, while southbound trading averaged over HKD 1.2 billion [2] - Hong Kong plans to include RMB trading counters in the Stock Connect and encourage more companies to increase RMB stock trading counters [2] Group 4: Offshore RMB Business Center - Hong Kong processes approximately 75% of global offshore RMB payments, with RMB deposits reaching around CNY 1 trillion by the end of August [2] - The government aims to optimize RMB liquidity arrangements to enhance the offshore RMB market's hub function [2] Group 5: Green and Sustainable Finance - In the previous year, Hong Kong issued green and sustainable bonds totaling approximately USD 43 billion, accounting for about 45% of the total in Asia, maintaining its leading position for seven consecutive years [3] Group 6: Collaboration with the Greater Bay Area - Hong Kong will strengthen its collaboration with the Greater Bay Area's carbon market, testing cross-border trading settlement paths [4]

Core Insights - The 10th China Pharmaceutical Innovation and Investment Conference was successfully held in Nanjing from October 26 to 27, highlighting discussions on pharmaceutical R&D achievements and investment trends in the industry [1] Group 1: Market Dynamics - The Hong Kong Stock Exchange (HKEX) plays a crucial role in supporting the globalization of Chinese innovative pharmaceutical companies through its efficient and diverse international financing platform [1] - The healthcare sector in Hong Kong has seen significant IPO activity this year, ranking first globally in terms of fundraising in the new stock market [1] - As of now, Hong Kong has completed 12 biotech IPOs, raising a total of $1.3 billion, which positions it as the leading market for biotech fundraising globally [1] Group 2: Financing Trends - The biotech sector has experienced active refinancing transactions, with a total refinancing amount reaching $4.1 billion year-to-date, indicating a gradual recovery in market confidence [2] - The positive performance in the healthcare financing market is attributed to the continuous optimization of regulatory frameworks, the listing of high-quality innovative companies, and active investor participation [1]

Core Viewpoint - The speech by Dr. Huang Tianyou emphasizes the importance of Hong Kong as a leading international financial center, focusing on maintaining market integrity and promoting market development while adapting to global changes [1][5]. Group 1: Market Resilience and Activity - Hong Kong's capital market has shown resilience, maintaining orderly operations despite global market volatility, with no incidents of defaults or systemic risks reported [1][2]. - In the first three quarters of this year, new IPOs in Hong Kong raised HKD 180 billion, a twofold increase year-on-year, while subsequent stock issuances raised HKD 260 billion, up 270% [2]. - The average daily trading volume in the Hong Kong stock market increased by over 90% compared to the same period last year, with a market capitalization nearing HKD 50 trillion, ranking third in Asia [2]. Group 2: Development Initiatives - The Hong Kong Securities and Futures Commission (SFC) and the Monetary Authority have launched a roadmap to develop the fixed income and currency markets, aiming to enhance market depth and breadth [2]. - The growth of the fixed income market is expected to facilitate corporate financing and meet diverse investor needs, promoting a win-win situation for issuers and investors [2]. Group 3: Cross-Border Cooperation - The mutual connectivity between mainland China and Hong Kong has effectively facilitated two-way capital flow, with mainland enterprises raising HKD 140 billion through IPOs in Hong Kong in the first nine months of this year [3]. - The collaboration between Beijing and Hong Kong is seen as crucial for building a strong financial nation and enhancing financial openness [3][4]. - The SFC supports financial institutions based in Beijing to expand their business in Hong Kong, promoting talent mobility and shared growth opportunities [4]. Group 4: Future Outlook - The SFC believes that through collaboration with mainland regulatory bodies, the capital markets of both regions can seize historical opportunities and create a more resilient, innovative, and diverse development platform [5].

Hong Kong's market regulator is conducting a comprehensive review of the listing regime to attract more innovative companies, while also closely monitoring how firms use digital assets as part of their treasury operations, according to the chairman of the Securities and Futures Commission (SFC). "These ongoing reviews will promote the market development of Hong Kong while at the same time ensure sufficient investor protection is in place," Kelvin Wong Tin-yau said in a media briefing on Tuesday. There was ...